Scientists have made a disturbing discovery: over 3,600 chemicals originating from food packaging and other consumer products have been detected in human blood and urine. This study, conducted by researchers at the University of Birmingham, sheds light on the previously underestimated burden of everyday products on the human body. Scope and Methodology of the Study The investigation, published in the journal ‘Environmental Science & Technology’, analyzed blood and urine samples from 56 individuals. State-of-the-art analytical methods were employed, enabling the identification of a wide range of chemicals that had previously gone undetected. Concerning Findings Diversity of Substances Found: Among the detected chemicals are plasticizers, flame retardants, and even substances known in the industry as ‘forever chemicals’ because they hardly break down in the environment. Health Risks: Many of these substances are suspected of causing hormonal disorders and potentially contributing to cancer. The long-term… 

A 25-year-old woman is the first person to have Type 1 diabetes treated with her own cells – an allogeneic transplant. She began producing her own insulin less than three months after the transplantation of reprogrammed stem cells. In a remarkable departure from the usual procedure, the cells were injected into the woman's abdominal muscles. Most islet cell transplants are injected into the liver, where the cells are not visible as they are in the abdominal cavity. For this study, patient-specific chemically induced PSCs (CiPSCs) were generated using the chemical reprogramming approach previously described by the team and then differentiated in vitro into insulin-producing islet-like cells using their established protocol. On day 75, the patient achieved complete insulin independence. She remained insulin-independent for the one-year follow-up period thereafter https://www.cell.com/cell/abstract/S0092-8674(24)01022-5

The vulnerability of supply chains in laboratory medicine is an important topic that has received little attention in Germany so far. Yet, there are good reasons to pay attention to it. Vulnerability of Supply Chains in Laboratory Medicine The supply chains in laboratory medicine are complex and susceptible to disruptions. The COVID-19 pandemic has clearly highlighted the weaknesses, but other factors also contribute to vulnerability. Dependence on a Few Suppliers A major problem is the strong dependence on a few suppliers, particularly from China and India. For example, over 80% of the world's active pharmaceutical ingredients are produced in these two countries[2]. Bottlenecks or production failures there can quickly lead to global supply problems. Complexity of Supply Chains The increasing complexity and specialization of pharmaceutical supply chains present another challenge[2]. Many products go through numerous production steps at various locations worldwide. This makes the chains vulnerable to disruptions. Lack of Transparency…